Medicamentsen-ligne vous propose les traitements dont vous avez besoin afin de prendre soin de votre santé sexuelle. Avec plus de 6 ans d'expérience et plus de 80.000 clients francophones, nous étions la première clinique fournissant du acheter levitra original en France à vente en ligne et le premier vendeur en ligne de Levitra dans le monde. Pourquoi prendre des risques si vous pouvez être sûr avec Medicamentsen-ligne - Le service auquel vous pouvez faire confiance.

Microsoft word - rehsfil0.wwi

SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
PRODUCT INFORMATION
Product name
Design Code
Dangerous for
the environment
Telephone
Emergency
telephone number

2. COMPOSITION/INFORMATION ON INGREDIENTS

Hazardous components
For the full text of the R phrases mentioned in this Section, see Section 16.
3. Hazards identification
Toxic in contact with skin and if swallowed. Harmful: danger of serious damage to health by prolonged exposure in contact with skin and if swallowed. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
4. FIRST AID MEASURES
General advice
: Have the product container, label or Material Safety Data Sheet with you when calling the Syngenta emergency number, a poison control center or physician, or going for treatment. Inhalation
Keep patient warm and at rest. If breathing is irregular or stopped, administer artificial respiration. Call a physician or Poison Control Centre immediately. SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5
Skin contact
: Take off all contaminated clothing immediately. Wash off immediately with plenty of water. If skin irritation persists, call a physician. Wash contaminated clothing before re-use. Eye contact
: Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. Remove contact lenses. Immediate medical attention is required. Ingestion

Symptoms
: Symptoms of poisoning are typical of anticoagulants. In severe cases there may be bruising, haematomas of the joints, blood in the faeces and urine Medical advice
: This product contains anticoagulants with an effect similar to warfarin in that they act by interfering with the synthesis of prothrombin. The specific measure of effect is the prothrombin time. Note this may not become prolonged until 12-18 hours after ingestion. The specific antidote is vitamin K1 (Phytomenandione) Antidote must be administered under medical supervision. Initially, antidote should be given by injection (10-20mg, or 0.25mg/kg for children, by slow intravenous infusion at a rate not exceeding 1mg/minute. In severe cases the use of fresh frozen plasma may be required). Maintenance treatment is given orally (40mg/day in divided doses for adults; up to 20mg/day in divided doses for children) The prothrombin time and the haemoglobin should be monitored. Patients should be kept under medical supervision until the prothrombin time has been normal for 3 consecutive days. Oral treatment may need continuing for several months (20mg/day in divided doses for adults and up to 20mg/day in divided doses for children). (For animal cases the dose is 2-5mg/kg)
5. FIRE-FIGHTING MEASURES
Suitable extinguishing
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. Extinguishing media - large fires alcohol-resistant foam water spray Extinguishing media
: Do not use a solid water stream as it may scatter and spread which must not be used
for safety reasons

Specific hazards during
: As the product contains combustible organic components, fire SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5
fire fighting
will produce dense black smoke containing hazardous products of combustion (see section 10). Exposure to decomposition products may be a hazard to health. Special protective
: In the event of fire, wear self-contained breathing apparatus. equipment for fire-
fighters

Further information
: Do not allow run-off from fire fighting to enter drains or water courses. Cool closed containers exposed to fire with water spray.
6. ACCIDENTAL RELEASE MEASURES
Personal precautions
: Refer to protective measures listed in sections 7 and 8. Environmental
: Prevent further leakage or spillage if safe to do so. precautions
Do not flush into surface water or sanitary sewer system.
Methods for cleaning up
: Contain and collect spillage with non-combustible absorbent material, (e.g. sand, earth, diatomaceus earth, vermiculite) and place in container for disposal according to local / national regulations (see section 13). Additional advice
: If the product contaminates rivers and lakes or drains inform
7. HANDLING AND STORAGE
HANDLING
Advice on safe handling
: No special protective measures against fire required. Avoid contact with skin and eyes. When using, do not eat, drink or smoke. For personal protection see section 8. Requirements for storage
: No special storage conditions required. areas and containers
Keep containers tightly closed in a dry, cool and well-ventilated place. Keep out of the reach of children. Keep away from food, drink and animal feedingstuffs. SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5

8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Components with workplace control parameters
ENGINEERING MEASURES
Containment and/or segregation is the most reliable technical protection measure if exposure cannot be eliminated. The extent of these protection measures depends on the actual risks in use. If airborne mists or vapors are generated, use local exhaust ventilation controls. Assess exposure and use any additional measures to keep airborne levels below any relevant exposure limit. Where necessary, seek additional occupational hygiene advice. PERSONAL PROTECTIVE EQUIPMENT
Protective measures
: The use of technical measures should always have priority over the use of personal protective equipment. When selecting personal protective equipment, seek appropriate professional advice. Personal protective equipment should be certified to appropriate standards. Respiratory protection
: No personal respiratory protective equipment normally required. A particulate filter respirator may be necessary until effective technical measures are installed. Hand protection
: Chemical resistant gloves should be used. Gloves should be certified to an appropriate standard. Gloves should have a minimum breakthrough time that is appropriate to the duration of exposure. The breakthrough time of gloves varies according to the thickness, material and manufacturer. Gloves should be changed when breakthrough is suspected. Suitable material: nitrile rubber Eye protection
: Eye protection is not usually required. Follow any site specific eye protection policies. Skin and body protection
: Assess the exposure and select chemical resistant clothing based on the potential for contact and the permeation / penetration characteristics of the clothing material. Wash with soap and water after removing protective clothing. Decontaminate clothing before re-use, or use disposable equipment (suits, aprons, sleeves, boots, etc.) Wear as appropriate: impervious protective suit SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5

9. PHYSICAL AND CHEMICAL PROPERTIES
Boiling point/range
Flash point
Oxidizing properties
Explosive properties
Vapour pressure
Solubility in other solvents

10. STABILITY AND REACTIVITY
Hazardous decomposition
: Combustion or thermal decomposition will evolve toxic and products
Hazardous reactions
Hazardous polymerization does not occur. Stable under normal conditions.
11. TOXICOLOGICAL INFORMATION

Acute oral toxicity

Acute inhalation toxicity

Acute dermal toxicity

Skin irritation
SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5

Eye irritation

Sensitization
Not a sensitizer Remarks: Derived from components Long term toxicity
Did not show carcinogenic, teratogenic or mutagenic effects in animal experiments. Excessive exposure slows blood clotting time and can cause bleeding, shock and death., This information applies to brodifacoum.
12. ECOLOGICAL INFORMATION
ELIMINATION INFORMATION (PERSISTENCE AND DEGRADABILITY)
Bioaccumulation
: Brodifacoum has high potential to bioaccumulate. Stability in water
Stability in soil
Mobility

ECOTOXICITY EFFECTS

Toxicity to fish
: LC50 Oncorhynchus mykiss (rainbow trout), 2 mg/l , 96 h
Toxicity to aquatic
: EC50 Daphnia magna (Water flea), 36 mg/l , 48 h invertebrates

13. DISPOSAL CONSIDERATIONS
: Where possible recycling is preferred to disposal or incineration. It must undergo special treatment, e.g. at suitable disposal site, to comply with local regulations. Contaminated packaging
SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5

14. TRANSPORT INFORMATION


Land transport
COUMARIN DERIVATIVE PESTICIDE, LIQUID, TOXIC ( BRODIFACOUM )

Sea transport
COUMARIN DERIVATIVE PESTICIDE, LIQUID, TOXIC ( BRODIFACOUM )
Marine pollutant :


Air transport
COUMARIN DERIVATIVE PESTICIDE, LIQUID, TOXIC ( BRODIFACOUM )
15. REGULATORY INFORMATION
Labelling according to EC Directives
Hazardous components which must be listed on the label:
Symbol(s)
SAFETY DATA SHEET according to EC directive 2001/58/EC
KLERAT
Version 5
R-phrase(s)
Toxic in contact with skin and if swallowed. Harmful: danger of serious damage to health by prolonged exposure in contact with skin and if swallowed. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
S-phrase(s)
Wear suitable protective clothing and gloves. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). This material and its container must be disposed of as hazardous waste. Avoid release to the environment. Refer to special instructions/safety data sheets. : The preparation is classified as dangerous in accordance with
16. OTHER INFORMATION
Further information
Text of R phrases mentioned in Section 2: Very toxic in contact with skin and if swallowed. R48/24/25
Toxic: danger of serious damage to health by prolonged exposure in contact with skin and if swallowed. Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process, unless specified in the text. A vertical bar in the left margin indicates an amendment from the previous version. Product names are a trademark or registered trademark of a Syngenta Group Company.

Source: http://www.rentokil.com.ph/files/file_423311.pdf

Mcptrieu

CYCLOPHOSPHAMIDE AND PREDNISONE AS SALVAGE THERAPY FOR MM Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation YOUNG TRIEU, MSC; SUZANNE TRUDEL, MD; GREGORY R. POND, MSC; JOSEPH MIKHAEL, MD;WILFRID JAKSIC, MD; DONNA E. REECE, MD; CHRISTINE I. CHEN, MD; AND

Tender proposal eoc

Study on Racial Encounters and Discrimination Experienced by South Asians Executive Summary Background 1. A survey on “Study on Racial Encounters and Discrimination Experienced by South Asians” was commissioned by the Equal Opportunities Commission (EOC) to the Centre for Civil Society and Governance, The University of Hong Kong, and the Policy 21 Limited. Interviews

Copyright © 2010-2014 Pharmacy Pills Pdf